S-1/A: Origin Investment Corp I Files Amended IPO Prospectus for $60M SPAC Offering Targeting Asia's Growth Sectors

Origin Investment Corp I, a blank check company, filed an amended S-1 registration statement for its initial public offering of 6 million units at $10.00 each, aiming to raise $60 million to pursue business combinations in Asia's financial services, technology, biotech, advanced materials, and clean energy sectors.

Summary

• Origin Investment Corp I is a blank check company incorporated in the Cayman Islands on September 25, 2024, with the purpose of effecting a business combination with one or more businesses.
• The company is offering 6,000,000 units at $10.00 per unit, each consisting of one ordinary share and one-half of one redeemable warrant, aiming to raise $60,000,000.
• The underwriters have a 45-day option to purchase up to an additional 900,000 units to cover over-allotments.
• The sponsor, Origin Equity LLC, will purchase 355,000 private units (or up to 373,000 with over-allotment) at $10.00 per unit for an aggregate of $3,550,000 (or up to $3,730,000).
• The company intends to focus its search for a target business on private companies in Asia, excluding entities in China or with China operations consolidated through a VIE structure.
• Target industries include Financial Services, Technology, Biotechnology & Pharmaceutical, Advanced Materials, and Clean Energy.
• A total of $60,600,000 (or $69,690,000 if over-allotment is exercised) will be deposited into a trust account, representing $10.10 per unit.
• The company has 24 months from the closing of the offering to consummate an initial business combination, with potential for extensions requiring shareholder approval.
• Public shareholders will have the opportunity to redeem their shares upon completion of a business combination or if no business combination is completed within the timeframe, at a per-share price equal to the pro rata portion of the trust account.
• The sponsor acquired 1,725,000 founder shares for $25,000, or approximately $0.014 per share, representing approximately 20% of outstanding shares post-offering (assuming forfeiture of 225,000 shares if over-allotment is not exercised).
• The company has no operating history and has generated no revenues to date, with activities focused on formation and the proposed IPO.
• As of March 31, 2025, the company had a net tangible book value deficit of $330,792, or approximately $(0.19) per ordinary share.
• Pro forma net tangible book value after the offering is estimated at $1,214,811 or $0.64 per share (assuming maximum redemption and no over-allotment exercise), resulting in an immediate dilution of $9.36 per share or 93.60% to public shareholders not exercising redemption rights.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the company presents a strong management team and a clear strategy to target high-growth Asian sectors, the inherent risks of a blank check company, significant dilution for public shareholders, and potential conflicts of interest temper any overly positive outlook. The lack of operating history and reliance on future business combination success also contribute to a neutral stance.

Positives

• The management team and board of directors possess extensive experience in financial services, accounting, technology, and senior operating roles across multiple jurisdictions, with decades of experience in M&A and IPOs.
• The company benefits from an established deal sourcing network, including industry executives, private owners, private equity funds, family offices, and investment bankers, which is expected to provide high-quality acquisition opportunities.
• Operating as a publicly listed company offers target businesses an attractive alternative to traditional IPOs, potentially being more cost-effective and offering greater certainty of execution.
• The company intends to focus on high-growth industries in Asia, including Financial Services, Technology, Biotechnology & Pharmaceutical, Advanced Materials, and Clean Energy, which are experiencing significant expansion and innovation.
• The Asian emerging market and developing economies are projected to expand 5.2% in 2024, outpacing overall global growth of 3.2%, indicating a favorable regional focus.
• The current tough IPO market and valuation environment in Asia Pacific (IPO proceeds dropped 33% in 2023) may make de-SPAC transactions a more attractive alternative for target companies, increasing business combination opportunities.
• Clean energy investment increased nearly 50% from 2019 to 2023, reaching $1.8 trillion in 2023, with solar PV and wind growing 85% and 60% respectively in 2023, highlighting a strong growth sector.
• The global advanced materials market is projected to reach $582.3 billion revenue by 2030, growing at an 8.2% CAGR, with Asia-Pacific leading the growth.
• The company's structure allows flexibility in using cash, debt, or equity securities for business combinations, enabling tailored consideration for target businesses.
• The sponsor has agreed to be liable for third-party claims against the trust account, reducing risk for public shareholders, though the sponsor's ability to satisfy this is not independently verified.

Negatives

• Public shareholders will incur immediate and material dilution of approximately 110.30% (or $11.03 per share) upon the closing of the offering, assuming no value is ascribed to warrants.
• The nominal purchase price paid by the sponsor for founder shares ($0.014 per share) creates a significant incentive for the sponsor to complete a business combination, even if it is unprofitable for public shareholders, as the founder shares could still yield substantial profit.
• The ability of public shareholders to redeem shares for cash may make the company's financial condition unattractive to potential business combination targets, potentially limiting desirable acquisition opportunities.
• A large number of redemptions could prevent the company from meeting minimum cash requirements for a business combination or force it to restructure the transaction, potentially leading to dilutive equity issuances or higher indebtedness.
• The 24-month deadline to complete a business combination may give target businesses leverage in negotiations and limit the time for due diligence, potentially leading to less favorable terms.
• The company has no operating history and no revenues, meaning investors have no basis to evaluate its ability to achieve its business objective.
• The company is exempt from Rule 419 blank check offering protections, meaning units are immediately tradable and there is a longer period to complete a business combination, but investors lack certain safeguards.
• Conflicts of interest exist due to officers and directors allocating time to other businesses and having fiduciary/contractual obligations to other entities, which may compete for business opportunities.
• The company may engage in a business combination with a private company about which little public information is available, potentially leading to an unprofitable acquisition.
• The company may be deemed a Passive Foreign Investment Company (PFIC), which could result in adverse U.S. federal income tax consequences for U.S. investors.
• Changes in laws or regulations, particularly the SEC's new SPAC Rules, may increase costs and time needed to complete a business combination and could lead to the company being deemed an investment company.
• Geopolitical conditions (Russia-Ukraine conflict, Middle East conflict) could adversely affect the search for a business combination, leading to market volatility, decreased liquidity, and unavailable third-party financing.
• The company's warrant agreement allows for amendments adverse to public warrant holders with approval of 50% of outstanding public warrants, potentially increasing exercise price, shortening exercise period, or decreasing shares purchasable.
• The company may redeem unexpired warrants prior to their exercise at a disadvantageous time for holders, potentially making them worthless.
• The issuance of a substantial number of warrants could make the company a less attractive acquisition vehicle and dilute the value of ordinary shares upon exercise.

Risks

• No operating history and no revenues, making it difficult to evaluate the company's ability to achieve its business objective.
• Public shareholders may not have an opportunity to vote on the proposed initial business combination, and even if a vote is held, founder shares will participate, potentially leading to approval without majority public shareholder support.
• The only opportunity for public shareholders to effect their investment decision regarding a potential business combination may be limited to exercising redemption rights for cash.
• The sponsor controls the appointment of the board of directors until the initial business combination, potentially exerting substantial influence on shareholder votes.
• The ability of public shareholders to redeem shares for cash may make the company's financial condition unattractive to potential business combination targets.
• The ability of public shareholders to exercise redemption rights with a large number of shares may prevent the completion of the most desirable business combination or optimize capital structure, leading to substantial dilution.
• The 24-month deadline to complete a business combination may give potential target businesses leverage and limit due diligence time.
• Sponsor, initial shareholders, directors, officers, and their affiliates may purchase shares or public warrants from public shareholders, potentially influencing a vote on a proposed business combination and reducing public float.
• Failure to receive notice of redemption offer or comply with procedures may result in shares not being redeemed.
• Officers and directors allocate time to other businesses, causing conflicts of interest in time commitment to the company's affairs.
• Public shareholders have no rights or interests in funds from the trust account except under limited circumstances, forcing them to sell shares or warrants, potentially at a loss, to liquidate investment.
• NASDAQ may delist securities, limiting investors' ability to trade and subjecting the company to additional restrictions.
• The nominal purchase price paid by the sponsor for founder shares results in significant dilution to the implied value of public shares upon business combination.
• The value of founder shares is likely to be substantially higher than the nominal price paid, even if public share trading price declines.
• Investors are not entitled to protections normally afforded to investors of Rule 419 blank check companies.
• Limited resources and significant competition for business combination opportunities may make it difficult to complete an initial business combination, potentially leading to public shareholders receiving only pro rata trust account funds and worthless warrants.
• Insufficient net proceeds outside the trust account may limit the search for a target business, requiring dependence on loans from the sponsor or management team.
• Past performance by the management team is not indicative of future performance.
• The company may be a Passive Foreign Investment Company (PFIC), resulting in adverse U.S. federal income tax consequences to U.S. investors.
• To mitigate PFIC risk, the company may liquidate trust account investments into cash, potentially reducing interest earned and the redemption/liquidation amount for public shareholders.
• A U.S. federal excise tax could be imposed on redemptions if the initial business combination involves a U.S. company and the company domesticates.
• Being deemed an investment company under the Investment Company Act could impose burdensome compliance requirements and restrict activities.
• Changes in laws or regulations, or non-compliance, may adversely affect the business and ability to complete a business combination.
• Continued effects of the COVID-19 pandemic, debt/equity market status, and protectionist legislation may adversely affect the search for a business combination.
• Current global geopolitical conditions (Russia-Ukraine, Middle East conflicts) may materially adversely affect the search for a business combination and target businesses.
• Military conflicts may lead to increased volume and price volatility for publicly traded securities or affect target companies' financial condition.
• Reincorporation in another jurisdiction may result in taxes for shareholders or warrant holders and may affect legal rights enforcement.
• Uncertain U.S. federal income tax consequences for investors.
• The initial business combination and subsequent structure may not be tax-efficient, leading to more complex, burdensome, or uncertain tax obligations.
• Subsequent write-downs, restructurings, or impairment charges post-business combination could negatively affect financial condition and security prices.
• Loss of a target business's key personnel could negatively impact post-combination operations and profitability.
• Management may not maintain control of a target business after the initial business combination.
• Limited ability to assess target business management, potentially leading to a combination with a company whose management lacks public company experience.
• Seeking complex business combination opportunities may delay or prevent desired results.
• No specified maximum redemption threshold, potentially allowing completion of a business combination not supported by a substantial majority of shareholders.
• Ability to amend warrant terms adversely to public warrant holders with 50% approval.
• Warrants may have an adverse effect on the market price of ordinary shares and make business combination more difficult.
• Units contain one-half of one warrant, potentially making them worth less than units of other SPACs with whole warrants.
• Warrants may not be exercisable unless underlying shares are registered or exemptions are available, potentially making them worthless.
• Cashless exercise of warrants results in fewer ordinary shares than cash exercise.
• Grant of registration rights to sponsor and other holders may make business combination more difficult and adversely affect market price of ordinary shares.

Future Outlook

The company intends to focus its search for a target business on private companies in Asia with compelling economics, clear paths to positive operating cash flow, and successful management teams seeking access to U.S. public capital markets. It expects to capitalize on its management team's expertise and network in financial services, technology, biotechnology & pharmaceutical, advanced materials, and clean energy sectors. The company anticipates that the tough IPO market in Asia Pacific will make de-SPAC transactions an attractive alternative for targets. It will not generate operating revenues until the earliest completion of its initial business combination and expects to incur increased expenses as a public company. The company aims to complete a business combination within 24 months from the IPO closing, with potential for extensions.

Management Comments

• "We believe our management team is well positioned to identify opportunities offering attractive risk-adjusted returns and that our professional contacts and transaction sources... will enable us to pursue a broad range of opportunities."
• "We believe that our structure will make us an attractive business combination partner to target businesses. As an existing public company, we offer a target business an alternative to the traditional initial public offering through a merger or other business combination."
• "We intend to initially focus on target businesses in Asia. In particular, we intend to focus our search for a target business on private companies in Asia that have compelling economics, clear paths to positive operating cash flow, and successful management teams that are seeking access to the U.S. public capital markets."
• "We believe that the technological breakthroughs-including generative AI, blockchain, cloud migration, and cybersecurity enhancement-will open up new strategic opportunities [in Financial Services]."
• "Pivotal and continuous advancements in AI have created compelling investment opportunities and are expected to fuel long-term sector growth [in Technology]."
• "We believe that the dynamics suggest extensive business combination opportunities [in Biotechnology & Pharmaceutical]."
• "The Asia-Pacific region is anticipated to lead the growth [in Advanced Materials], attributed to the high concentration of manufacturers and robust industrial activities within the area."
• "The shift towards sustainable energy sources is accelerating the growth of the clean energy sector... This growth is supported by worldwide initiatives to reduce reliance on fossil fuels and mitigate environmental impacts."
• "Our management team intends to focus on creating shareholder value by leveraging its experience in the management, operation, and financing of businesses to improve the efficiency of operations while implementing strategies to scale revenue organically and/or through acquisitions."
• "We believe that the operating expertise of our management team is well suited to complement many potential targets management teams."
• "We intend to acquire a business or businesses that will benefit from being publicly traded and which can effectively utilize access to broader sources of capital and a public profile that are associated with being a publicly traded company."
• "We do not believe that our anticipated activities will subject us to the Investment Company Act."
• "We will endeavor to cause any lower-tier PFIC to provide to a U.S. Holder the information that may be required to make or maintain a QEF election with respect to the lower-tier PFIC. However, there is no assurance that we will have timely knowledge of the status of any such lower-tier PFIC."

Industry Context

The company positions itself as a solution for Asian private companies seeking access to U.S. public capital markets, particularly in a challenging IPO environment where Asia Pacific IPO proceeds dropped 33% in 2023. This aligns with a broader trend of de-SPAC transactions becoming an alternative to traditional IPOs. The focus on Financial Services (driven by AI, blockchain, cloud, cybersecurity), Technology (AI-fueled growth), Biotechnology & Pharmaceutical (constant innovation, M&A activity), Advanced Materials (Asia-Pacific growth leadership), and Clean Energy (accelerated growth, significant investment) reflects an intent to target high-growth, innovation-driven sectors that are experiencing transformative changes and increased investment globally.

Comparison to Industry Standards

• The company's unit structure, offering one-half of one redeemable warrant per unit, is presented as a way to reduce the dilutive effect of warrants compared to other SPACs that offer whole warrants, aiming to be a more attractive business combination partner.
• The company highlights that its offering is not conducted in compliance with Rule 419 blank check offerings, meaning investors will not receive the same protections (e.g., immediate tradability of units, longer period to complete business combination).
• The company's initial listing on NASDAQ is a standard practice for SPACs, but it notes that maintaining listing requires meeting certain financial, distribution, and share price levels, similar to other public companies.
• The company's management team's prior accomplishments and current activities are presented as critical in identifying attractive acquisition opportunities, implicitly comparing their expertise to other market participants.
• The company acknowledges intense competition from other SPACs, private equity groups, leveraged buyout funds, and operating businesses, noting that many competitors possess greater financial, technical, human, and other resources.
• The company's commitment to deposit at least 90% of gross proceeds into a trust account aligns with NASDAQ rules, similar to other SPACs.
• The company's ability to extend the business combination period beyond 24 months with shareholder approval is a common feature among SPACs, but it emphasizes 'no limitations on extensions' which could be a differentiator or a risk depending on interpretation.
• The company's intention to acquire a target business with an aggregate fair market value of at least 80% of the trust account balance is a standard NASDAQ requirement for SPACs.

Management Changes

Corporate Governance

Legal Proceedings

• No material litigation, arbitration, or governmental proceeding is currently pending against the company or any members of its management team in their capacity as such.

Related Party Transactions

• The sponsor, Origin Equity LLC, purchased 1,725,000 founder shares for $25,000 (approximately $0.014 per share) on September 25, 2024.
• The sponsor will transfer 25,000 founder shares to Kuo-Shui (Ringo) Chao, 13,000 to Daniel Alef, and 13,000 to Derek Alef as compensation for their services as directors, contingent on their remaining with the company until business combination closing.
• The sponsor has agreed to purchase 355,000 private units (or up to 373,000 with over-allotment) at $10.00 per unit in a private placement concurrent with the IPO.
• The company will pay the sponsor $25,000 per month for office space, administrative, and support services, ceasing upon business combination completion or liquidation.
• The sponsor, officers, and directors, or their affiliates, will be reimbursed for out-of-pocket expenses incurred in identifying and investigating target businesses, with no cap on reimbursement.
• The sponsor loaned the company up to $500,000 via an unsecured promissory note for offering expenses; $221,988 was outstanding as of March 31, 2025, and is expected to be repaid from IPO proceeds.
• The sponsor or affiliates may provide working capital loans up to $1,500,000 to finance transaction costs, convertible into private units at $10.00 per unit at the lender's option.
• The company has entered into a registration rights agreement with the sponsor and other initial shareholders for founder shares, private units, and working capital loan units.
• The company may engage its sponsor or an affiliate as an advisor for the initial business combination and pay market-standard fees, but no such arrangements are currently in place.

Stakeholder Impact

• **Shareholders (Public):** Will experience immediate and material dilution (approx. 93.60% to 110.30%) due to the low cost basis of founder shares. Their investment is subject to the company successfully completing a business combination within 24 months, or they will receive a pro rata redemption of funds from the trust account, potentially less than $10.10 per share due to taxes and potential creditor claims. They may have limited voting influence on the business combination due to sponsor's voting power and may be restricted from redeeming more than 15% of their shares in certain scenarios.
• **Shareholders (Sponsor/Initial):** Stand to make a substantial profit even if the post-combination share price declines significantly, due to their nominal purchase price for founder shares. They have significant control over the company's direction and board appointments prior to a business combination. Their investment is at risk if no business combination is completed within the timeframe, as their founder shares and private units would expire worthless.
• **Employees (Post-Combination):** The target business's management team may remain in place, and the company may seek to recruit additional managers. The success of the combined entity will impact their employment stability and potential incentives.
• **Customers/Suppliers (Post-Combination):** The target business's public listing status is expected to augment its profile, potentially attracting new customers and vendors.
• **Creditors:** Funds in the trust account are generally protected from third-party claims, but there's a risk that claims could reduce the per-share redemption amount if waivers are not obtained or enforceable. The sponsor has agreed to indemnify the trust account against certain claims, but its ability to satisfy this is not independently verified.
• **Underwriters:** Receive underwriting commissions and ThinkEquity units, and have a 45-day over-allotment option. They also have a right of first refusal for future financial advisory and capital raising services for 24 months post-business combination.

Next Steps

• Complete the initial public offering and list units on NASDAQ under symbol ORIQU.
• Begin separate trading of ordinary shares (ORIQ) and public warrants (ORIQW) on the 52nd day following the prospectus date, or earlier if the underwriter allows.
• File a Current Report on Form 8-K with the SEC containing an audited balance sheet reflecting receipt of gross proceeds from the offering.
• Identify and select one or more target businesses for an initial business combination within 24 months from the closing of the offering.
• Conduct thorough due diligence on prospective target businesses.
• Negotiate and execute definitive agreements for the initial business combination.
• Seek shareholder approval for the business combination if required by law or NASDAQ rules, or conduct a tender offer.
• If unable to complete a business combination within 24 months, or an extended period, redeem 100% of outstanding public shares and liquidate the company.
• Establish and maintain an audit committee and compensation committee upon effectiveness of the registration statement.
• Adopt a Code of Ethics prior to the closing of the offering.

Key Dates

Keywords

SPAC, Special Purpose Acquisition Company, IPO, Blank Check Company, Asia Investment, Financial Services, Technology, Biotechnology, Pharmaceutical, Advanced Materials, Clean Energy, Merger, Acquisition, De-SPAC, Warrants, Dilution, Trust Account, SEC Filing, S-1/A, NASDAQ Listing